+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Washington Legal Cannabis Market Size, Share & Trends Analysis Report by Source (Hemp, Marijuana), Derivatives (CBD, THC), End-use (Industrial Use, Medical Use), and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 110 Pages
  • June 2024
  • Region: United States
  • Grand View Research
  • ID: 5983019
The Washington legal cannabis market size is expected to reach USD 3.34 billion by 2030, registering a CAGR of 14.4% from 2024 to 2030. Factors such as growing consumer disposable income, legalization of medicinal cannabis, growing consumer awareness of the health benefits of cannabis, increasing demand for cannabis from the pharmaceutical industry, and the approval of the U.S. Farm Bill are expected to boost the market growth.

Cannabis is widely utilized for managing a range of health conditions, including cancer, mental health issues, pain, and nausea, and for recreational purposes. The growing incidence of cancer is anticipated to significantly contribute to the growing acceptance of medical marijuana over the forecast period. For instance, according to an article published by the American Cancer Society in January 2023, 609,820 cancer deaths and 1,958,310 new cancer cases were projected to occur in the U.S. in 2023. In the U.S., two CBD drugs (nabilone and dronabinol) are approved by the FDA for the treatment of vomiting and nausea caused by chemotherapy.

In addition, the rise in cannabis certification programs and growing awareness among people regarding the therapeutic benefits of cannabis boosts market growth. For instance, Washington-based Tacoma Community College offers a 9-week online certificate program that gives an understanding of the cannabis supply chain and the skills needed to excel in the cannabis cultivation environment. Moreover, there is a growing demand for various CBD-infused products, such as beverages, cannabis oil, beauty products, capsules, gummies, etc. Various methods, such as vaping, smoking, or topical application, can introduce CBD into the body. In Washington, cannabis is legal, and CBD is employed to develop personal care products and medicinal products. The legalization of cannabis-based products created significant expansion opportunities for various industries to broaden their range of products.

Furthermore, new technologies and improvements are continually being developed for cannabis cultivation. With an increasing demand for technologically advanced cannabis production, these expanded techniques are anticipated to assist cultivators in optimizing their resources, further driving the market's growth.

Washington Legal Cannabis Market Report Highlights

  • By source, the marijuana segment accounted for the largest revenue share in 2023, owing to the recognition of cannabis for medical purposes and growing research studies for its therapeutic benefits
  • By derivatives, the CBD segment dominated the market with the largest revenue share in 2023, due to rise in demand for CBD-infused food, cosmetics, and medication
  • By end use, the recreational use segment held the largest market share in 2023 due to the growing demand for cannabis for smoking and consuming it in the form of foods & beverage

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets


This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Source
1.2.2. Derivatives
1.2.3. End-use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.2.1. Source outlook
2.2.2. Derivatives outlook
2.2.3. End-use outlook
2.3. Competitive Landscape Snapshot
Chapter 3. Washington Legal Cannabis Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Case Study Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
3.4. Regulatory Landscape
Chapter 4. Washington Legal Cannabis Market Segment Analysis, By Source, 2018-2030 (USD Million)
4.1. Definition and Scope
4.2. Source Segment Dashboard
4.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4. Hemp
4.4.1. Market estimates and forecasts, 2018-2030 (USD Million)
4.4.2. Hemp CBD
4.4.2.1. Market estimates and forecasts, 2018-2030 (USD Million)
4.4.3. Industrial Hemp
4.4.3.1. Market estimates and forecasts, 2018-2030 (USD Million)
4.5. Marijuana
4.5.1. Market estimates and forecasts, 2018-2030 (USD Million)
4.5.2. Flower
4.5.2.1. Market estimates and forecasts, 2018-2030 (USD Million)
4.5.3. Oil and Tinctures
4.5.3.1. Market estimates and forecasts, 2018-2030 (USD Million)
Chapter 5. Washington Legal Cannabis Market Segment Analysis, By Derivatives, 2018-2030 (USD Million)
5.1. Definition and Scope
5.2. Derivatives Segment Dashboard
5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4. CBD
5.4.1. Market estimates and forecasts, 2018-2030 (USD Million)
5.5. THC
5.5.1. Market estimates and forecasts, 2018-2030 (USD Million)
5.6. Others
5.6.1. Market estimates and forecasts, 2018-2030 (USD Million)
Chapter 6. Washington Legal Cannabis Market Segment Analysis, By End-use, 2018-2030 (USD Million)
6.1. Definition and Scope
6.2. End-use Segment Dashboard
6.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4. Industrial Use
6.4.1. Market estimates and forecasts, 2018-2030 (USD Million)
6.5. Medical Use
6.5.1. Market estimates and forecasts, 2018-2030 (USD Million)
6.5.2. Chronic Pain
6.5.2.1. Market estimates and forecasts, 2018-2030 (USD Million)
6.5.3. Depression and Anxiety
6.5.3.1. Market estimates and forecasts, 2018-2030 (USD Million)
6.5.4. Arthritis
6.5.4.1. Market estimates and forecasts, 2018-2030 (USD Million)
6.5.5. Post-traumatic Stress Disorder (PTSD)
6.5.5.1. Market estimates and forecasts, 2018-2030 (USD Million)
6.5.6. Cancer
6.5.6.1. Market estimates and forecasts, 2018-2030 (USD Million)
6.5.7. Migraines
6.5.7.1. Market estimates and forecasts, 2018-2030 (USD Million)
6.5.8. Epilepsy
6.5.8.1. Market estimates and forecasts, 2018-2030 (USD Million)
6.5.9. Alzheimer’s
6.5.9.1. Market estimates and forecasts, 2018-2030 (USD Million)
6.5.10. Multiple Sclerosis
6.5.10.1. Market estimates and forecasts, 2018-2030 (USD Million)
6.5.11. Amyotrophic Lateral Sclerosis
6.5.11.1. Market estimates and forecasts, 2018-2030 (USD Million)
6.5.12. Tourette’s
6.5.12.1. Market estimates and forecasts, 2018-2030 (USD Million)
6.5.13. Diabetes
6.5.13.1. Market estimates and forecasts, 2018-2030 (USD Million)
6.5.14. Parkinson's
6.5.14.1. Market estimates and forecasts, 2018-2030 (USD Million)
6.5.15. Glaucoma
6.5.15.1. Market estimates and forecasts, 2018-2030 (USD Million)
6.5.16. Others
6.5.16.1. Market estimates and forecasts, 2018-2030 (USD Million)
6.6. Recreational Use
6.6.1. Market estimates and forecasts, 2018-2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, by Key Market Participants
7.2. Company Categorization
7.3. Company Market Position Analysis
7.4. Company Profiles
7.4.1. NORTHWEST CANNABIS SOLUTIONS
7.4.1.1. Overview
7.4.1.2. Financial Performance
7.4.1.3. Service Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. The Hollingsworth Cannabis Company, LLC
7.4.2.1. Overview
7.4.2.2. Financial Performance
7.4.2.3. Service Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Alkaloid Cannabis Company
7.4.3.1. Overview
7.4.3.2. Financial Performance
7.4.3.3. Service Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Herbs House
7.4.4.1. Overview
7.4.4.2. Financial Performance
7.4.4.3. Service Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. Nirvana Cannabis
7.4.5.1. Overview
7.4.5.2. Financial Performance
7.4.5.3. Service Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. Edgemont Group (Leafwerx)
7.4.6.1. Overview
7.4.6.2. Financial Performance
7.4.6.3. Service Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. OLYMPIA WEED COMPANY
7.4.7.1. Overview
7.4.7.2. Financial Performance
7.4.7.3. Service Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. Canna West Seattle
7.4.8.1. Overview
7.4.8.2. Financial Performance
7.4.8.3. Service Benchmarking
7.4.8.4. Strategic Initiatives
7.4.9. Grow Op Farms (Phat Panda)
7.4.9.1. Overview
7.4.9.2. Financial Performance
7.4.9.3. Service Benchmarking
7.4.9.4. Strategic Initiatives
7.4.10. Forbidden Farms, LLC
7.4.10.1. Overview
7.4.10.2. Financial Performance
7.4.10.3. Service Benchmarking
7.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Washington legal cannabis market, by source, 2018-2030 (USD Million)
Table 4 Washington legal cannabis market, by derivatives, 2018-2030 (USD Million)
Table 5 Washington legal cannabis market, by end-use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Value-chain-based sizing & forecasting
Figure 5 QFD modeling for market share assessment
Figure 6 Market research approaches
Figure 7 Market formulation & validation
Figure 8 U.S. cannabis market: market outlook
Figure 9 U.S. cannabis competitive insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook.
Figure 12 Industry value chain analysis
Figure 13 Washington legal cannabis market driver impact
Figure 14 Washington legal cannabis market restraint impact
Figure 15 Washington legal cannabis market: Source movement analysis
Figure 16 Washington legal cannabis market: Source outlook and key takeaways
Figure 17 Hemp market estimates and forecasts, 2018-2030 (USD Million)
Figure 18 Hemp CBD market estimates and forecasts, 2018-2030 (USD Million)
Figure 19 Industrial hemp market estimates and forecasts, 2018-2030 (USD Million)
Figure 20 Marijuana market estimates and forecasts, 2018-2030 (USD Million)
Figure 21 Flower market estimates and forecasts, 2018-2030 (USD Million)
Figure 22 Oil and tinctures market estimates and forecasts, 2018-2030 (USD Million)
Figure 23 Washington legal cannabis market: Derivatives movement analysis
Figure 24 Washington legal cannabis market: Derivatives outlook and key takeaways
Figure 25 CBD market estimates and forecasts, 2018-2030 (USD Million)
Figure 26 THC market estimates and forecasts, 2018-2030 (USD Million)
Figure 27 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 28 Washington legal cannabis market: End-use movement analysis
Figure 29 Washington legal cannabis market: End-use outlook and key takeaways
Figure 30 Industrial use market estimates and forecasts, 2018-2030 (USD Million)
Figure 31 Medical use market estimates and forecasts, 2018-2030 (USD Million)
Figure 32 Chronic pain market estimates and forecasts, 2018-2030 (USD Million)
Figure 33 Depression and anxiety market estimates and forecasts, 2018-2030 (USD Million)
Figure 34 Arthritis market estimates and forecasts, 2018-2030 (USD Million)
Figure 35 Post-traumatic stress disorder (PTSD) market estimates and forecasts, 2018-2030 (USD Million)
Figure 36 Cancer market estimates and forecasts, 2018-2030 (USD Million)
Figure 37 Migraines market estimates and forecasts, 2018-2030 (USD Million)
Figure 38 Epilepsy market estimates and forecasts, 2018-2030 (USD Million)
Figure 39 Alzheimer’s market estimates and forecasts, 2018-2030 (USD Million)
Figure 40 Multiple sclerosis market estimates and forecasts, 2018-2030 (USD Million)
Figure 41 AIDS market estimates and forecasts, 2018-2030 (USD Million)
Figure 42 Amyotrophic lateral sclerosis market estimates and forecasts, 2018-2030 (USD Million)
Figure 43 Tourette’s market estimates and forecasts, 2018-2030 (USD Million)
Figure 44 Diabetes market estimates and forecasts, 2018-2030 (USD Million)
Figure 45 Parkinson's market estimates and forecasts, 2018-2030 (USD Million)
Figure 46 Glaucoma market estimates and forecasts, 2018-2030 (USD Million)
Figure 47 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 48 Recreational Use market estimates and forecasts, 2018-2030 (USD Million)
Figure 49 Key company categorization

Companies Mentioned

  • NORTHWEST CANNABIS SOLUTIONS
  • The Hollingsworth Cannabis Company, LLC
  • Alkaloid Cannabis Company
  • Herbs House
  • Nirvana Cannabis
  • Edgemont Group (Leafwerx)
  • OLYMPIA WEED COMPANY
  • Canna West Seattle
  • Grow Op Farms (Phat Panda)
  • Forbidden Farms, LLC

Methodology

Loading
LOADING...

Table Information